nach oben

Erschienen in:

02.05.2017 | Research Letter

Is levothyroxine requirement the same for tablet and soft gel formulations?

verfasst von: Vincenzo Di Donna, Rosa Maria Paragliola, Chiara de Waure, Giampaolo Papi, Alfredo Pontecorvi, Salvatore Maria Corsello

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

Synthetic levothyroxine (LT₄) sodium is the gold standard for the treatment of hypothyroidism, but finding the individually tailored LT₄ dose level is still challenging [1, 2]. …

A.M. Formenti, G. Mazziotti, R. Giubbini, A. Giustina, Treatment of hypothyroidism: all that glitters is gold? Endocrine 52, 411–413 (2016)CrossRefPubMed

P. Colucci, C. Seng Yue, M. Ducharme, S. Benvenga, A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur. Endocrinol. 9, 40–47 (2013)CrossRef

R. Vita, P. Fallahi, A. Antonelli, S. Benvenga, The administration of L-thyroxine as soft gel capsule or liquid solution. Expert Opin. Drug Deliv. 11, 1103–1011 (2014)CrossRefPubMed

V. Di Donna, M.G. Santoro, C. de Waure, M.P. Ricciato, R.M. Paragliola, A. Pontecorvi, S.M. Corsello, A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease. Thyroid 24, 1759–1764 (2014)CrossRefPubMed

D. Mistry, S. Atkin, H. Atkinson, S. Gunasekaran, D. Sylvester, A.S. Rigby, R.J. England, Predicting thyroxine requirements following total thyroidectomy. Clin. Endocrinol. 74, 384–387 (2011)CrossRef

F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M.G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, T. Rago, C. Mammoli, R. Elisei, P. Vitti, Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid disease. J. Clin. Endocrinol. Metab. 90, 124–127 (2005)CrossRefPubMed

C. Virili, P. Trimboli, F. Romanelli, M. Centanni, Liquid and softgel levothyroxine use in clinical practice: state of the art. Endocrine 54, 3–14 (2016)CrossRefPubMed

D. Al-Numani, C. Scarsi, M.P. Ducharme, Levothyroxine soft capsules demonstrate bioequivalent pharmacokinetic exposure with the European reference tablets in healthy volunteers under fasting conditions. Int. J. Clin. Pharmacol. Ther. 54, 135–143 (2016)CrossRefPubMed

R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43, 154–160 (2013)CrossRefPubMed

10.

M.G. Santaguida, C. Virili, S.C. Duca, M. Cellini, I. Gatto, N. Brusca, C. De Vito, L. Gargano, M. Centanni, Thyroxine softgel capsule in patients with gastric-related T4 malabsorption. Endocrine 49, 51–57 (2015)CrossRefPubMed

11.

C. Cappelli, I. Pirola, E. Gandossi, A. Cristiano, L. Daffini, B. Agosti, C. Casella, M. Castellano, Hormone profile in patients ingesting soft gel capsule or liquid levothyroxine formulations with breakfast. Int. J. Endocrinol. (2016). doi:10.1155/2016/9043450

12.

P. Fallahi, S.M. Ferrari, A. Antonelli, Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine 52, 597–560 (2016)CrossRefPubMed

13.

D. Brancato, A. Scorsone, G. Saura, L. Ferrara, A. Di Noto, V. Aiello, M. Fleres, V. Provenzano, Comparison of TSH levels with liquid formulation versus tablet formulations of levothyroxine in the treatment of adult hypothyroidism. Endocr. Pract. 20, 657–662 (2014)CrossRefPubMed

14.

R. Negro, R. Valcavi, D. Agrimi, K.A. Toulis, Levothyroxine liquid solution versus tablet for replacement treatment in hypothyroid patients. Endocr. Pract. 20, 901–906 (2014)CrossRefPubMed

15.

C.P. Lombardi, R. Bocale, A. Barini, A. Barini, A. D’Amore, M. Boscherini, R. Bellantone, Comparative study between the effects of replacement therapy with liquid and tablet ormulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients. Endocrine 55, 51–59 (2016)CrossRefPubMed

16.

A. Cassio, S. Monti, A. Rizzello, I. Bettocchi, F. Baronio, G. D’Addabbo, M.O. Bal, A. Balsamo, Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J. Pediatr. 162, 1264–1269 (2013)CrossRefPubMed

17.

E. Peroni, M.C. Vigone, S. Mora, L.A. Bassi, C. Pozzi, A. Passoni, G. Weber, Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm. Res. Paediatr. 81, 50–54 (2014)CrossRefPubMed

18.

L. Chaker, M.E. van den Berg, M.N. Niemeijer, O.H. Franco, A. Dehghan, A. Hofman, P.R. Rijnbeek, J.W. Deckers, M. Eijgelsheim, B.H. Stricker, R.P. Peeters, Thyroid function and sudden cardiac death: a prospective population-based cohort study. Circulation 134, 713–722 (2016)CrossRefPubMed

Titel: Is levothyroxine requirement the same for tablet and soft gel formulations?
verfasst von: Vincenzo Di Donna
Rosa Maria Paragliola
Chiara de Waure
Giampaolo Papi
Alfredo Pontecorvi
Salvatore Maria Corsello
Publikationsdatum: 02.05.2017
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-017-1311-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Is levothyroxine requirement the same for tablet and soft gel formulations?

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Transoral endoscopic thyroidectomy via a vestibular approach: why and how?

Effects of chronic endurance exercise training on serum 25(OH)D concentrations in elderly Japanese men

Bone marrow fat contributes to insulin sensitivity and adiponectin secretion in premenopausal women

Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia

Quality of life in hypoparathyroidism

The tear cytokine profile in patients with active Graves’ orbitopathy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin